FDA Inspection
Samer K. Khaled, M.D.Samer K. Khaled, M.D. – FDA Inspection, Dec 23, 2020
Record Details
This FDA Inspection record concerns Samer K. Khaled, M.D., with an inspection on December 23, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Samer K. Khaled, M.D.
- Inspection Date
- December 23, 2020
- Product Type
- Drugs
View Company Profile
ID · 3fd02b90-972c-4a31-b547-f32412363d4e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1134243
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Samer K. Khaled, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Samer K. Khaled, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.